Sex-chromosome complement and Activin-A shape the therapeutic potential of TNFR2 activation in a model of MS and CNP
Proceedings of the National Academy of Sciences, Volume 122, Issue 20, May 2025. SignificanceThis study highlights the critical role of sex-chromosome complement and gonadal Activin-A in therapeutic efficacy of TNFR2